Skip to main content

. 1972 Mar;34(3):252–259. doi: 10.1136/hrt.34.3.252

Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.

J L Reynolds, R M Whitlock

PMCID: PMC458466 PMID: 4111391

252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Arstila M., Iisalo E., Kallio V. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent. Ann Clin Res. 1969 May;1(1):13–21. [PubMed] [Google Scholar]
Briant R. B., Norris R. M. Alprenolol in acute myocardial infarction: Double-blind trial. N Z Med J. 1970 Mar;71(454):135–138. [PubMed] [Google Scholar]
DOMENET J. G., EVANS D. W., HOWARTH F. H. CLINICAL EXPERIENCE WITH RADIOLOGICAL DETERMINATION OF HEART VOLUME. Br Heart J. 1963 Sep;25:575–582. doi: 10.1136/hrt.25.5.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
Deming Q. B. Blood pressure; its relation to atherosclerotic disease of the coronaries. Bull N Y Acad Med. 1968 Aug;44(8):968–984. [PMC free article] [PubMed] [Google Scholar]
Denborough M. A., Lovell R. R., Nestel P. J., Goble A. J. Arrhythmias and late sudden death after myocardial infarction. Lancet. 1968 Feb 24;1(7539):386–388. doi: 10.1016/s0140-6736(68)91354-8. [DOI] [PubMed] [Google Scholar]
GERTLER M. M., DRISKELL M. M., BLAND E. F., GARN S. M., LERMAN J., LEVINE S. A., SPRAGUE H. B., WHITE P. D. Clinical aspects of coronary heart disease; an analysis of 100 cases in patients 23 to 40 years of age with myocardial infarction. J Am Med Assoc. 1951 Aug 4;146(14):1291–1295. doi: 10.1001/jama.1951.03670140017005. [DOI] [PubMed] [Google Scholar]
McKenna D. H., Corliss R. J., Sialer S., Zarnstorff W. C., Crumpton C. W., Rowe G. G. Effect of propranolol on systemic and coronary hemodynamics at rest and during simulated exercise. Circ Res. 1966 Sep;19(3):520–527. doi: 10.1161/01.res.19.3.520. [DOI] [PubMed] [Google Scholar]
Norris R. M., Caughey D. E., Scott P. J. Trial of propranolol in acute myocardial infarction. Br Med J. 1968 May 18;2(5602):398–400. doi: 10.1136/bmj.2.5602.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
Parratt J. R., Wadsworth R. M. Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats. Br J Pharmacol. 1969 Oct;37(2):357–366. [PMC free article] [PubMed] [Google Scholar]
Snow P. J. Effect of propranolol in myocardial infarction. Lancet. 1965 Sep 18;2(7412):551–553. doi: 10.1016/s0140-6736(65)90863-9. [DOI] [PubMed] [Google Scholar]
Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]
Wolfson S., Heinle R. A., Herman M. V., Kemp H. G., Sullivan J. M., Gorlin R. Propranolol and angina pectoris. Am J Cardiol. 1966 Sep;18(3):345–353. doi: 10.1016/0002-9149(66)90052-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES